Table 2 Antibiotic susceptibility results for carbapenem-resistant Klebsiella pneumoniae isolates.

From: Clinical characteristics and mortality risk factors of premature infants with carbapenem-resistant Klebsiella pneumoniae bloodstream infection

Antibiotic

Isolates tested

Sensitive (% of tested)

Intermediate (% of tested)

Resistance (% of tested)

Piperacillin/tazobactam

96

0

0

96 (100)

Ceftazidime

96

0

0

96 (100)

Amtrazumab

96

0

0

96 (100)

Imipenem

96

0

0

96 (100)

Meropenem

96

0

0

96 (100)

Amikacin

96

25 (26)

0

71 (73.9)

ciprofloxacin

96

17 (17.7)

3 (3.1)

76 (79.2)

Tigecycline

85

84 (98.8)

1 (1.2)

0

Polymyxin B

86

84 (97.7)

0

2(2.3)

TMP/SMX

85

62 (72.9)

3 (3.5)

20 (23.5)

  1. TMP/SMX Trimethoprim/sulfamethoxazole; CAZ/AVI ceftazidime-avibactam.